Literature DB >> 23259511

The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community.

Ruedi Aebersold1, Gary D Bader, Aled M Edwards, Jennifer E van Eyk, Martin Kussmann, Jun Qin, Gilbert S Omenn.   

Abstract

The biology and disease oriented branch of the Human Proteome Project (B/D-HPP) was established by the Human Proteome Organization (HUPO) with the main goal of supporting the broad application of state-of the-art measurements of proteins and proteomes by life scientists studying the molecular mechanisms of biological processes and human disease. This will be accomplished through the generation of research and informational resources that will support the routine and definitive measurement of the process or disease relevant proteins. The B/D-HPP is highly complementary to the C-HPP and will provide datasets and biological characterization useful to the C-HPP teams. In this manuscript we describe the goals, the plans, and the current status of the of the B/D-HPP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23259511     DOI: 10.1021/pr301151m

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  38 in total

1.  Data-Driven Approach To Determine Popular Proteins for Targeted Proteomics Translation of Six Organ Systems.

Authors:  Maggie P Y Lam; Vidya Venkatraman; Yi Xing; Edward Lau; Quan Cao; Dominic C M Ng; Andrew I Su; Junbo Ge; Jennifer E Van Eyk; Peipei Ping
Journal:  J Proteome Res       Date:  2016-07-19       Impact factor: 4.466

2.  Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes.

Authors:  Rajasree Menon; Hogune Im; Emma Yue Zhang; Shiaw-Lin Wu; Rui Chen; Michael Snyder; William S Hancock; Gilbert S Omenn
Journal:  J Proteome Res       Date:  2013-11-07       Impact factor: 4.466

3.  MOPED enables discoveries through consistently processed proteomics data.

Authors:  Roger Higdon; Elizabeth Stewart; Larissa Stanberry; Winston Haynes; John Choiniere; Elizabeth Montague; Nathaniel Anderson; Gregory Yandl; Imre Janko; William Broomall; Simon Fishilevich; Doron Lancet; Natali Kolker; Eugene Kolker
Journal:  J Proteome Res       Date:  2013-12-18       Impact factor: 4.466

4.  Priorities and trends in the study of proteins in eye research, 1924-2014.

Authors:  Richard D Semba; Maggie Lam; Kai Sun; Pingbo Zhang; Debra A Schaumberg; Luigi Ferrucci; Peipei Ping; Jennifer E Van Eyk
Journal:  Proteomics Clin Appl       Date:  2015-09-16       Impact factor: 3.494

Review 5.  The Human Eye Proteome Project: perspectives on an emerging proteome.

Authors:  Richard D Semba; Jan J Enghild; Vidya Venkatraman; Thomas F Dyrlund; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-08       Impact factor: 3.984

6.  The human eye proteome project.

Authors:  Gilbert S Omenn
Journal:  Proteomics       Date:  2013-08       Impact factor: 3.984

7.  Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.

Authors:  Gilbert S Omenn
Journal:  Biochim Biophys Acta       Date:  2013-11-08

8.  Metrics for the Human Proteome Project 2013-2014 and strategies for finding missing proteins.

Authors:  Lydie Lane; Amos Bairoch; Ronald C Beavis; Eric W Deutsch; Pascale Gaudet; Emma Lundberg; Gilbert S Omenn
Journal:  J Proteome Res       Date:  2013-12-23       Impact factor: 4.466

Review 9.  Developing top down proteomics to maximize proteome and sequence coverage from cells and tissues.

Authors:  Dorothy R Ahlf; Paul M Thomas; Neil L Kelleher
Journal:  Curr Opin Chem Biol       Date:  2013-08-27       Impact factor: 8.822

10.  State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project.

Authors:  Terry Farrah; Eric W Deutsch; Gilbert S Omenn; Zhi Sun; Julian D Watts; Tadashi Yamamoto; David Shteynberg; Micheleen M Harris; Robert L Moritz
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.